2315

HKSE:2315

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Stock

HKD

Last Close

6.37

30/08 07:58

Market Cap

3.05B

Beta: -

Volume Today

153K

Avg: 161.05K

PE Ratio

−7.72

PFCF: −5.73

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '20	Dec '21	Dec '22	Dec '23
net income	-476.69M -	-545.64M 14.46%	-601.35M 10.21%	-382.95M 36.32%
depreciation and amortization	43.37M -	128.10M 195.38%	174.10M 35.91%	189.98M 9.12%
deferred income tax	101.47M -	4.58M 95.49%
stock based compensation	132.45M -	27.75M 79.05%	15.31M 44.82%	30.98M 102.28%
change in working capital	-29.24M -	-10.18M 65.19%	95.65M 1,039.75%
accounts receivables	-32.38M -	-35.86M 10.75%	-4.59M 87.19%
inventory	-7.78M -	-34.44M 342.69%	-10.84M 68.51%
accounts payables	32.38M -	35.86M 10.75%	4.59M 87.19%
other working capital	-21.46M -	24.26M 213.05%	106.49M 338.98%
other non cash items	3.33M -	29.61M 790.35%	13.03M 56.01%	85.35M 555.16%
net cash provided by operating activities	-225.31M -	-365.78M 62.34%	-303.27M 17.09%	-76.65M 74.73%
investments in property plant and equipment	-306.42M -	-198.67M 35.16%	-240.67M 21.14%
acquisitions net	10M -		-6.86M -
purchases of investments	-1.27B -	-540M 57.65%	-9.31M 98.28%
sales maturities of investments	1.39B -	649.78M 53.36%	101.46M 84.38%
other investing activites	-9.96M -	4.76M 147.79%	1.64M 65.63%	-100.28M 6,233.21%
net cash used for investing activites	-188.18M -	-84.13M 55.29%	-153.74M 82.74%	-100.28M 34.77%
debt repayment	-16.85M -	-57.13M 239.06%	-29.99M 47.51%
common stock issued	98.36M -	311.04M 216.23%	521.05M 67.52%
common stock repurchased			-18.99M -
dividends paid
other financing activites	786.93M -	-34.47M 104.38%	115.12M 433.99%	-37.82M 132.85%
net cash used provided by financing activities	868.44M -	219.44M 74.73%	587.20M 167.59%	-37.82M 106.44%
effect of forex changes on cash	-4.04M -	-380K 90.59%	14.24M 3,847.63%	3.47M 75.65%
net change in cash	450.91M -	-230.85M 151.20%	144.44M 162.57%	-211.28M 246.27%
cash at beginning of period	246.38M -	697.29M 183.01%	466.44M 33.11%	610.88M 30.97%
cash at end of period	697.29M -	466.44M 33.11%	610.88M 30.97%	399.61M 34.59%
operating cash flow	-225.31M -	-365.78M 62.34%	-303.27M 17.09%	-76.65M 74.73%
capital expenditure	-306.42M -	-198.67M 35.16%	-240.67M 21.14%
free cash flow	-531.73M -	-564.45M 6.15%	-543.94M 3.63%	-76.65M 85.91%

All numbers in HKD (except ratios and percentages)